Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.6 |
mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |